Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

NuVasive to Participate in Investor Events in December 2014

November 24, 2014 – 2:05 pm | Edit Post

SAN DIEGO, CA–(Marketwired – Nov 24, 2014) – NuVasive, Inc. ( NASDAQ : NUVA ), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that management will participate in the following investor events in December 2014:

Peptic ulcer, cancer bacteria therapy discovery

November 24, 2014 – 1:00 pm | Edit Post

Vegetable oil ingredient may provide cheap way to control infection billions have.

Obese Children Burdened by More than Weight

November 24, 2014 – 12:00 pm | Edit Post

High blood pressure and nonalcoholic fatty liver disease (NAFLD) are two emerging health problems related to the epidemic of childhood obesity. In a recent study, researchers at University of California, San Diego School of Medicine sought to determine the prevalence of high blood pressure in children with NAFLD, which places them at risk for premature cardiovascular disease.

Sleep Apnea Linked to Poor Aerobic Fitness

November 24, 2014 – 9:31 am | Edit Post

People with moderate to severe obstructive sleep apnea may have an intrinsic inability to burn high amounts of oxygen during strenuous aerobic exercise according to a new study led by researchers at University of California, San Diego School of Medicine.

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am | Edit Post

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am | Edit Post

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

Physician-Scientist Shares his Journey to Help Those with Autoimmune Diseases

November 24, 2014 – 7:00 am | Edit Post

Professor Hugh Rosen spoke to donors about his experiences with drug discovery at a recent lecture hosted by TSRI’s Office of Philanthropy.

Researchers Discover New Type of Neuron that Plays Key Role in Nicotine Addiction

November 24, 2014 – 7:00 am | Edit Post

“If we can find a way to target those neurons in humans, maybe we can reduce the ‘high’ produced by the drug and reduce the withdrawal symptoms,” says Assistant Professor Olivier George.

Team Reveals Weak Spots in Ebola’s Defenses

November 24, 2014 – 7:00 am | Edit Post

The new study from the Ward and Saphire labs exposes how experimental drug ZMapp attacks the virus and suggests strategies to improve future therapies.

Cells’ Response to Chronic Protein Misfolding May Do More Harm than Good

November 24, 2014 – 7:00 am | Edit Post

The study from the Balch lab suggests diseases such as cystic fibrosis and Alzheimer’s can be seriously exacerbated by the body’s response, providing fundamental insights with implications for the design of new therapies.